publication date: Jun. 29, 2018

CTEP Protocol

NCI Trials for June

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

For further information, contact the principal investigator listed.

 

Phase II – 10170

A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies

Yale University Cancer Center LAO

Aggarwal, Rahul Raj

(415) 353-9278

 

Phase II/III – AHEP1531

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

Children’s Oncology Group

Tiao, Gregory M.

(513) 636-2292

 

Phase III – CCTG CE.7

A Phase III Trial of Stereotactic Radiosurgery Compared with Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases

Canadian Cancer Trials Group

Roberge, David

(514) 890-8254

 

Phase III – S1600

A Randomized Phase III Double Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes

SWOG

Hamilton-Reeves, Jill M.

(913) 588-7650

 

Phase Other – AALL18B1-Q

Effectiveness of LSD1 Inhibition on Viability of Patient-Derived T-ALL Isolates

Children’s Oncology Group

Engel, Michael Eugene

(801) 587-3882

 

Phase Other – AOST15B3-Q

Defining and Targeting the Tumor Immune Microenvironment in Osteosarcoma

Children’s Oncology Group

Roth, Michael E.

(713) 792-7751

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.